HKHannah Kim

Hannah Kim

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Hannah Kim has a total of 71 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Public Readiness for AI-Enabled Brain-Computer Interfaces in a Six-Country Survey (Preprint)

    by Hannah Kim, Minjee Lee, HyeonJeong Park, Yann Joly, Jusaku Minari, Timo Minssen, Louise C. Druedahl, Go Yoshizawa, Jae-Hyun Lee, Diya Uberoi, et al.

    BACKGROUND As brain-computer interfaces (BCIs) increasingly incorporate artificial intelligence, understanding public readiness for their clinical translation is important. However, cross-national evidence on willingness to use emerging BCI technologies, particularly when framed within nanomedicine, remains limited. OBJECTIVE To evaluate cross-national public readiness for a proposed brain-computer interface (BCI) and identify factors associated with willingness to use it in the context of emerging AI-enabled BCIs. METHODS We conducted a cross-sectional online survey from April 9, 2022, through December 23, 2022, among 6,000 adults (1,000 per country) in Canada, Japan, South Korea, the United States, Germany, and Denmark. Using a hypothetical scenario involving a brain disorder such as Parkinson’s disease, respondents indicated their willingness to use nano link technology for themselves or a family member. Adjusted logistic regression models examined factors associated with willingness. RESULTS Overall, 3,748 respondents (62.5%) were willing to use the proposed technology, ranging from 56.6% in the United States to 74.0% in South Korea. Perceived benefits for improved patient self-control (adjusted odds ratio [aOR], 4.66; 95% CI, 4.02-5.41) and real-time disease prevention (aOR, 2.93; 95% CI, 2.55-3.37) showed the strongest adjusted associations with willingness. Concerns about autonomy and overheating associated with real-time data collection were reported by 39.0% and 36.9% of respondents, respectively. CONCLUSIONS Public willingness to use the proposed BCI was substantial across all six countries but varied across national settings. Therapeutic expectations were strongly associated with willingness, while autonomy and safety concerns remained salient considerations for the responsible development and governance of emerging AI-enabled BCIs.

  • Open Access

    Public Readiness for AI-Enabled Brain-Computer Interfaces in a Six-Country Survey

    by Minjee Lee, HyeonJeong Park, Yann Joly, Jusaku Minari, Timo Minssen, Louise C. Druedahl, Go Yoshizawa, Jae-Hyun Lee, Diya Uberoi, Il Ho Lee, et al.

    Background AI-enabled brain-computer interfaces (BCIs) are emerging clinical technologies supported by advances in artificial intelligence, neural engineering, and nanomedicine, yet cross-national evidence on public readiness for their use remains limited. Methods We conducted a cross-sectional, six-country public survey between April 9 and Dec 23, 2022, among 6,000 adults (1,000 per country) in Canada, Japan, South Korea, the United States, Germany, and Denmark. Using a brain disorder such as Parkinson’s disease as a hypothetical clinical scenario, respondents indicated their willingness to use a proposed BCI for themselves or a family member, with the findings considered in the broader context of emerging AI-enabled BCIs. Adjusted logistic regression models examined factors associated with willingness. Findings Overall, 3,748 (62.5%) respondents were willing to use nano link technology; willingness was highest in South Korea (740 [74.0%]) and lowest in the United States (566 [56.6%]). Agreement was more frequent for improved patient self-control (4,416 [73.6%]) and real-time disease prevention (4,108 [68.5%]) than for autonomy concerns (2,341 [39.0%]) or concerns about overheating associated with real-time data collection (2,214 [36.9%]). In the fully adjusted model, the strongest associations with willingness were perceived benefit for patient self-control (adjusted odds ratio [aOR] 4.66, 95% CI 4.02-5.41) and real-time disease prevention (aOR 2.93, 2.55-3.37). Interpretation Public willingness to use AI-enabled BCIs was substantial overall and exceeded 50% in every surveyed country, although it varied across countries. Therapeutic expectations were the strongest correlates of willingness, while concerns about autonomy and overheating associated with real-time data collection remained salient and should inform responsible development and governance.

  • Open Access

    Parental Consent Approaches for Newborn Whole-Genome Sequencing–Based Screening

    by HyeonJeong Park, Junghyun Lee, Wonhoo Yoo, Hannah Kim

    This study aims to develop a standardized informed consent system for whole-genome sequencing (WGS)-based newborn screening (NBS) in Korea through a policy design approach grounded in the domestic legal and policy context. We conducted an integrated literature review of international norms, domestic legal frameworks, guidelines, and major overseas WGS-based NBS programs using a common analytical framework. To develop a consent model feasible in the Korean context, we also analyzed stakeholder evidence from parent interviews and a clinician survey focused on consent-related issues. The findings indicate that the current Korean legal and institutional framework does not adequately address long-term storage, reanalysis, recontact, and the transfer of decision-making authority as the child matures. Based on these findings, we propose a Korean informed consent model consisting of a staged consent pathway spanning antenatal, postnatal, and adulthood-related decision points; tiered consent options for the return of results; and safeguards against disadvantage or discrimination related to participation, non-participation, or withdrawal. The study further suggests that implementation will require broader legal and procedural clarification across the relevant regulatory framework, along with the continued development of education and counseling strategies.

  • Open Access

    A Systematic Review for the Development of a Consent System for Newborn Screening Based on Whole-Genome Sequencing (WGS)

    by HyeonJeong Park, Hyunjae Cha, Wonhoo Yoo, Hannah Kim, Junhewk Kim, So-Yoon Kim

    Informed consent for whole-genome sequencing (WGS)-based newborn screening presents distinctive ethical and legal challenges, particularly in balancing parental consent given on behalf of the child with the progressive realization of children’s rights. This study examines the issues discussed in the literature and proposes consent frameworks that are responsive to evolving clinical and societal contexts. A systematic literature review was conducted in accordance with PRISMA 2020 guidelines, analyzing 19 empirical, normative, and legal studies. The synthesis identified persistent tensions between safeguarding parental autonomy and ensuring the child’s future self-determination, alongside challenges in determining the scope, timing, and format of genomic information disclosure. International models increasingly adopt dynamic consent processes, such as staged consent or re-consent upon reaching legal capacity. These approaches illustrate the feasibility of aligning clinical utility, public health objectives, and rights-based ethics within large-scale genomic programs. Based on its findings, this study recommends the implementation of staged consent mechanisms, transparent disclosure protocols, and procedural safeguards tailored to domestic legal and political frameworks. Such evolving consent practices are expected to support the development of ethically robust and socially sustainable governance for WGS-based newborn screening.


  • Open Access

    Advancing artificial intelligence ethics in health and genomics: lessons from a public survey in South Korea

    by Jungim Lee, Wonhoo Yoo, Hannah Kim

    Advances in healthcare and genetics are becoming increasingly integrated with artificial intelligence (AI), offering transformative potential alongside complex ethical challenges. This study aimed to assess public awareness and perceptions of AI ethics in healthcare (AI-H) in South Korea, with the ultimate goal of informing the development of research ethics guidelines. A nationwide online survey was conducted from January 10 to 20, 2023, targeting the general public, and 1,002 respondents were recruited through stratified random sampling. The questionnaire explored expectations of AI-H, perceived risks, willingness to share different types of personal data, and the perceived importance of various ethical principles and education targets. A large majority of respondents (84.5%) expressed optimism about the positive impacts of AI-H over the next five years, while only 3.1% anticipated negative consequences. Key concerns included the disclosure of personal information (54.0%), potential AI errors causing harm (52.0%), and ambiguous legal responsibilities (42.2%). Willingness to share data was highest for electronic medical records (72.8%), lifestyle data (72.3%), and biometric data (71.3%), while genetic data was least preferred (64.1%). Ethical principles considered most important were privacy protection (83.9%), safety and security (83.7%), legal duties (83.4%), and responsiveness (83.3%). Developers (70.7%), medical institution managers (68.2%), and researchers (65.6%) were identified as top priorities for ethics education, whereas the general public (31.0%) and students (18.7%) ranked lower. This study represents the first nationwide assessment of public ethical awareness of AI-H in South Korea. While there is strong support for AI-H, significant concerns remain, particularly regarding data privacy and legal accountability. The findings highlight the need for expanded ethics education, especially among younger populations, and for balanced attention to ethical principles beyond privacy, such as inclusiveness and accessibility. These insights provide valuable guidance for developing socially responsible AI policies and practices in healthcare.


  • Open Access

    South Korea’s Health Misinformation Response during COVID-19: A Narrative-Thematic Analysis

    by Sophia Wasti, Hajeong Lee, Hannah Kim

    Infodemics have emerged as a serious contemporary challenge to public health, especially in the context of the ongoing COVID-19 pandemic. This paper conducts a narrative thematic analysis exploring the South Korean response to the public health risks caused by misinformation, critically examining the legal, social, and ethical dimensions of dealing with the difficulties posed by health misinformation, identifying the following key themes: limitations posed by existing law in South Korea, government policies as a response to the COVID-19 pandemic, self-regulation in the private sector and mitigation of the social impacts of COVID-19 misinformation. The paper offers a thematic exploration of South Korea’s integrated policy response to health misinformation within the context of the global COVID-19 infodemic and highlights the South Korean effort to balance the protection of public health and welfare with citizen’s individual rights to freedom of expression and the necessity of flexibility and adaptive policies to effectively counter COVID-19 misinformation. It observes the importance of effective public health communication and provides insight useful for dealing with potential future challenges arising from the proliferation of health misinformation and mitigating the adverse impacts of infodemics on public health initiatives, using the example of South Korea.


  • Open Access

    Considerations for Implementing a Patient and Public Engagement Model of Healthcare AI

    by Junghyun Lee, Hannah Kim

    This commentary builds on the lead article for this volume by proposing additional considerations for implementing a healthcare AI framework centered on patients and citizens. It argues that rather than being mere data providers, patients and citizens must serve as external validators, thereby enhancing transparency and fairness in the development of healthcare AI. The participation of patients and citizens is essential to safeguarding the rights of data providers, ensuring transparent AI usage, and promoting equitable healthcare access. However, current domestic systems, including broad consent mechanisms, limit meaningful involvement. This commentary addresses these limitations by highlighting the need for centralized, provider-focused data governance, clear information dissemination, and ongoing education initiatives. Ultimately, while the participation of patients and citizens is crucial for fostering trust in healthcare AI, that participation must be supported with systematic strategies and long-term investments.


  • Open Access

    Developing a Framework for Self-regulatory Governance in Healthcare AI Research: Insights from South Korea

    by Junhewk Kim, So Yoon Kim, Eun-Ae Kim, Jin-Ah Sim, Yuri Lee, Hannah Kim

    This paper elucidates and rationalizes the ethical governance system for healthcare AI research, as outlined in the ‘Research Ethics Guidelines for AI Researchers in Healthcare’ published by the South Korean government in August 2023. In developing the guidelines, a four-phase clinical trial process was expanded to six stages for healthcare AI research: preliminary ethics review (stage 1); creating datasets (stage 2); model development (stage 3); training, validation, and evaluation (stage 4); application (stage 5); and post-deployment monitoring (stage 6). Researchers identified similarities between clinical trials and healthcare AI research, particularly in research subjects, management and regulations, and application of research results. In the step-by-step articulation of ethical requirements, this similarity benefits from a reliable and flexible use of existing research ethics governance resources, research management, and regulatory functions. In contrast to clinical trials, this procedural approach to healthcare AI research governance effectively highlights the distinct characteristics of healthcare AI research in research and development process, evaluation of results, and modifiability of findings. The model exhibits limitations, primarily in its reliance on self-regulation and lack of clear delineation of responsibilities. While formulated through multidisciplinary deliberations, its application in the research field remains untested. To overcome the limitations, the researchers’ ongoing efforts for educating AI researchers and public and the revision of the guidelines are expected to contribute to establish an ethical research governance framework for healthcare AI research in the South Korean context in the future.


  • Open Access

    Prioritization of research engaged with rare disease stakeholders: a systematic review and thematic analysis

    by Soho Yoon, Minjee Lee, Hoi-In Jung, M. Mahmud Khan, So-Yoon Kim, Hannah Kim, Sophia Wasti

    Background: Although rare diseases (RD) are increasingly becoming a priority for healthcare activities and services around the world, developing research policy for investigating RD in public settings proves challenging due to the limited nature of existing evidence. Rare conditions require the involvement of a wide range of stakeholders in order to promote general awareness and garner political support. Consequently, it is critically important to identify trends in the various types of research focusing on rare disease stakeholders, including the specific topics or issues to be included in surveys and studies focused on RD stakeholders. This systematic review and thematic analysis analyses the existing literature based on RD surveys, including the stakeholders involved, and proposes potential research priorities and initiatives for policy-making related to RD. Methods: Articles were downloaded and analyzed from across five electronic databases (PubMed, EMBASE, Cochrane Central, Web of Science, and CINHAL) and 115 studies were included. Results: Across 115 studies, the main research participants were patients and/or caregivers (n = 77, 67.0%), health professionals (n = 18, 15.7%), and the public (n = 7, 6.1%). The studies discussed RDs in general (n = 46, 40.0%), endocrine, nutritional, and metabolic diseases (n = 20, 17.4%) and other RDs. Experiences with RD were examined by more than half of the selected studies (n = 74, 64.3%), followed by the opinions of stakeholders (n = 24, 20.9%). Most of the studies used surveys in order to collect relevant data (n = 114, 99.1%). Additionally, the majority of the studies were conducted in high-income countries (n = 92, 80.0%) and rarely in middle and low-income countries (n = 12, 13.8%). Conclusion: Stakeholder research on RD reveals that there are significant instances of unmet needs and various challenges faced by the medical system in dealing with RDs. Furthermore, public awareness and support is critical to ensuring political feasibility of increasing national-level investments for RDs and development of medical products and treatment.